Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
JAMA Oncology|September 23, 2021
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy TrialAndrew X Zhu, Teresa Macarulla, Milind M Javle, et al.
Hepatology (Baltimore, Md.)|March 25, 2021
Genetic Determinants of Outcome in Intrahepatic CholangiocarcinomaThomas Boerner, Esther Drill, Linda M Pak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical PhenotypeMaeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
Journal of the National Cancer Institute|March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic NeoplasmsMaeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Cancer Discovery|October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase InhibitionJames J Harding, Maeve A Lowery, Alan H Shih, et al.
JAMA Oncology|November 1, 2019
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical TrialAndrea Cercek, Thomas Boerner, Benjamin R Tan, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2015
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapiesVincent J Picozzi, Ramesh K Ramanathan, Maeve A Lowery, et al.
JAMA|September 6, 2017
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline TestingDiana Mandelker, Liying Zhang, Yelena Kemel, et al.
Nature Medicine|May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Pageof 7